Case Report
Copyright ©The Author(s) 2016.
World J Clin Cases. Mar 16, 2016; 4(3): 88-93
Published online Mar 16, 2016. doi: 10.12998/wjcc.v4.i3.88
Figure 1
Figure 1 Clinical course of Case 1 of viral breakthrough during the combination treatment with daclatasvir and asunaprevir. RAVs: Resistance-associated variants; HCV: Hepatitis C virus; ALT: Alanine aminotransferase; UDCA: Ursodeoxycholic acid; DCV: Daclatasvir; ASV: Asunaprevir.